ChromaDex (NASDAQ: CDXC) reported Q4 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $21 million versus the consensus estimate of $21.22 million.

GUIDANCE:

Looking forward, for the full year, the Company expects at least 10% revenue growth, with a realistic possibility of significantly greater growth this year

For earnings history and earnings-related data on ChromaDex (CDXC) click here.